This document discusses perinatal asphyxia, which is a lack of oxygen and blood flow to the fetus or newborn during delivery resulting in tissue injury. It can be caused by issues with the placenta, umbilical cord, prolonged compression of the fetal head during delivery, or other maternal or fetal conditions. Left untreated, perinatal asphyxia can damage multiple organs but particularly impacts the brain, kidneys, and heart. Management involves maintaining adequate oxygen and blood flow as well as controlling seizures. Hypothermia therapy, keeping the infant's core temperature at 33°C for 72 hours, may help reduce brain injury from severe asphyxia. While multisystem effects are common, failure to breathe
2. PERINATAL ASPHYXIA
Insult to the fetus / Newborn
Lack of oxygen (Hypoxia)
Lack of perfusion (Ischemia)
Effect of hypoxia & Ischemia are inseparable
Both contribute to tissue injury
10. ETHIOLOGY
I - MATERNAL CAUSES: (conditions
leading to imperfect oxygenation
of maternal blood)
Severe anemia, Hemorrhage &
shock, Respiratory failure, and heart
failure.
Eclamptic seizure, pneumonia, and
pulmonary edema.
11. ETHIOLOGY
II- PLACENTAL CAUSES:
Placental compression: interfering with its
circulation as in tonically contracted uterus,
prolonged labour after rupture of the
membranes or as a method of control of
bleeding in placenta previa.
Placental separation as in accidental
hemorrhage.
Placental insufficiency e.g. extensive
degeneration, multiple infarcts & abnormally
small placenta.
12. ETHIOLOGY
III- CAUSES IN THE UMBILICAL CORD:
Obstruction of the circulation, which may be
due to:
Tight nucal cord
True knots
Prolapsed cord
Compression of the vessels by hematoma of
the cord
Rupture of vasa praevia.
13. ETIOLOGY ( cont…)
IV-PROLONGED COMPRESSION OF THE FETAL
HEAD:
This will cause edema and ischemia, which
interfere with the blood supply of the medulla
leading to depression of the respiratory center.
Prolonged compression may be due to:
Contracted pelvis (C/P disproportion).
Rigid perineum.
Intracranial hemorrhage.
Forceps application for a long time.
Depressed fracture
14. FACTORS
Mat. Oxygenation
Blood flow
mother to
placenta
Blood flow
placenta to
fetus
Gas Exchange
across placenta
or fetal tissue
Fetal O2 Req.
16. NONE BRAIN ORGAN DAMAGE
PATHOPHYSIOLOGY
Acute asphyxia
Diving reflex
Shunting of blood
to brain adrenals
& heart
Away from
lungs, kidney
gut & skin
23. NEUROPATHOLOCIAL CHANGES
Pattern seen in term infants
Selective neuronal necrosis (Spastic CP)
Status Marmoratus (Chorea, Athetoid, Dystonia)
Parasagittal cerebral injury (Prox Spastic
Quadriparesis)
Focal and multifocal ischemic brain injury (sp.
Hemiparesis, cognitive defects, seizure)
Pattern predominant in preterm
Periventricular leukomalacia
24. PATHOLOGY
Cerebral O2
Substrate supply
Synaptic inactivation (Reversible)
Energy failure
Memb. pump failure
Further in perfusion
At cellular level
25.
26. CHANGES IN SUBSTRATE METABOLISM
AND NEURTRANSMITTERS
Hypoxic effect
Changes that are increased
An initial increase Cerebral blood
flow
Increase of glucose influx to brain
Increase in glycogenolysis (increase
cAMP)
Increase in glycolysis (increase
cAMP)
27. CHANGES IN SUBSTRATE METABOLISM
AND NEURTRANSMITTERS
Changed that are decreased
Decreased oxidative
phosphorylation
Eventual decrease brain glucose
Decreased phosphocreatinine
(PCr) and ATP
These changes are more pronouned
in the white matter compared to the
gray matter
30. 12/11/2022 30
PULMONARY EFFECTS
Increased pulmonary resistance
pulmonary hemorrhage
Pulmonary edema secondary to cardiac failure
Failure of surfactant production with secondary HMD
Meconium aspiration may be present.
31. Management of HIE
1. Maintain O2 and CO2 in normal ranges.
2. Hyperventilation not recommended and may be
detrimental.
3. Monitor arterial blood pressure because cerebra perfusion
pressure is dependent on MAP
4. Administer volume slowly: overall fluid restriction
5. Monitor electrolytes and glucose
6. Control seizures
7. HYPOTHERMIA THERAPY
32. HYPOTHERMIA THERAPY
Entry criteria
PH < 7.0
Base deficit 16mmole/l in 1st hour
APGAR score < 5 at 10 minutes.
Less than 6 hrs old.
Technique
Keep core temp at 33 *C for 72 hrs
Continuous EEG monitoring
Continue medical management
33. MULTISYSTEMIC EFFECTS
Seizures
Often resitant to anticonvulsant therapy in severe HIE
(possibly because of a lack of cortical inhibition Vs.
excesive cortical activity
50% are subtle, focal ,multifocal or myoclonic
Typically first noted at age 12 to 24 hrs and often
resolve by 5 to 7 days
Must also assess for other metabolic derangements
(eg; hypoglycemia, hypocalcemia,
hypomagnesemia)
Phenobarbital is the first line agent followed by
dilantin (may also consider lorazepam)
34. MULTISYSTEMIC EFFECTS
ACUTE ASPHYXIA
elicits diving reflex with preferred blood flow to the brain,
heart, and adrenal gland
CARDIAC MANIFESTATIONS
Transient myocardial ischemia, congestive heart failure,
left or right ventricular dysfunction, tricuspid
regurgitation murmur within the first 24 hrs
RENAL
Oliguria and possible acute tubular necrosis
PULMONARY
Pulmonary hypertension especially after MAS
35. PREDICTORS OF POOR
NEURO DEVELOPMENTAL OUTCOME
Failure to establish respiration by 5 minutes
Apgar 3 or less in 5 mts
Onset of Seizure in 12 hrs
Refractory convulsion
Inability to establish oral feed by 1 wk
Abnormal EEG & failure to normalise by 7 days
of life
Abnormal CT, MRI in neonatal period